Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous ThromboembolismFrits R. Rosendaal, Marco Cattaneo, Maurizio Margaglione et al.|Thrombosis and Haemostasis|2001Cited by 235
Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C ResistancePaolo Bucciarelli, Roberto Quintavalla, Frits R. Rosendaal et al.|Arteriosclerosis Thrombosis and Vascular Biology|1999Cited by 161
Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registryElvira Grandone, Maurizio Margaglione, Eugenio Bucherini et al.|Human Reproduction|2021Cited by 37
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyValerio De Stefano, Tiziano Barbui|Blood|2019Cited by 34
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Filíppo Gherlinzoni, Francesca Palandri et al.|Cancer|2025Cited by 10